# Rapamycin, Acarbose and 17α-estradiol share common mechanisms regulating the MAPK pathways involved in intracellular signaling and inflammation

**URL:** <https://www.rapamycin.news/t/rapamycin-acarbose-and-17-estradiol-share-common-mechanisms-regulating-the-mapk-pathways-involved-in-intracellular-signaling-and-inflammation/668>\
**Category:** General\
**Created:** [February 2, 2022, 7:05pm UTC](https://www.rapamycin.news/t/rapamycin-acarbose-and-17-estradiol-share-common-mechanisms-regulating-the-mapk-pathways-involved-in-intracellular-signaling-and-inflammation/668 "2022-02-02T19:05:58Z")\
**Posts on this page:** 12\
**Page:** 1

<div class="post-metadata">

**Author:** ![RapAdmin](https://www.rapamycin.news/user_avatar/www.rapamycin.news/rapadmin/32/377_2.png) [@RapAdmin](https://www.rapamycin.news/u/RapAdmin)\
**Post date:** [February 2, 2022, 7:05pm UTC](https://www.rapamycin.news/t/rapamycin-acarbose-and-17-estradiol-share-common-mechanisms-regulating-the-mapk-pathways-involved-in-intracellular-signaling-and-inflammation/668/1 "2022-02-02T19:05:58Z")

</div>

Another new research paper from Richard Miller and the ITP researchers:

> **[Rapamycin, Acarbose and 17α-estradiol share common mechanisms regulating the...](https://immunityageing.biomedcentral.com/articles/10.1186/s12979-022-00264-1)**
>
> Background Rapamycin (Rapa), acarbose (ACA), and 17α-estradiol (17aE2, males only) have health benefits that increase lifespan of mice. Little is known about how these three agents alter the network of pathways downstream of insulin/IGF1 signals as...

---

<div class="post-metadata">

**Author:** ![shc](https://www.rapamycin.news/user_avatar/www.rapamycin.news/shc/32/750_2.png) [@shc](https://www.rapamycin.news/u/shc)\
**Post date:** [February 2, 2022, 7:16pm UTC](https://www.rapamycin.news/t/rapamycin-acarbose-and-17-estradiol-share-common-mechanisms-regulating-the-mapk-pathways-involved-in-intracellular-signaling-and-inflammation/668/2 "2022-02-02T19:16:19Z")

</div>

So this is independent of the effects acarbose has on starch digestion? I was of the belief that this was its only way for providing longevity benefits. But maybe not.

---

<div class="post-metadata">

**Author:** ![RapAdmin](https://www.rapamycin.news/user_avatar/www.rapamycin.news/rapadmin/32/377_2.png) [@RapAdmin](https://www.rapamycin.news/u/RapAdmin)\
**Post date:** [February 2, 2022, 7:19pm UTC](https://www.rapamycin.news/t/rapamycin-acarbose-and-17-estradiol-share-common-mechanisms-regulating-the-mapk-pathways-involved-in-intracellular-signaling-and-inflammation/668/3 "2022-02-02T19:19:52Z")

</div>

Yes - I find this very surprising. It also suggests that if the overlap on pathways is significant, we may not see much improvement if a person is taking all three compounds vs. just one.

---

<div class="post-metadata">

**Author:** ![shc](https://www.rapamycin.news/user_avatar/www.rapamycin.news/shc/32/750_2.png) [@shc](https://www.rapamycin.news/u/shc)\
**Post date:** [February 2, 2022, 8:13pm UTC](https://www.rapamycin.news/t/rapamycin-acarbose-and-17-estradiol-share-common-mechanisms-regulating-the-mapk-pathways-involved-in-intracellular-signaling-and-inflammation/668/4 "2022-02-02T20:13:12Z")

</div>

Acarbose is so cheap. I wonder what new protocols this will encourage.

However, tbh when I’ve taken acarbose I’ve noticed none of the body high type of feelings I get while fasting or while on rapamycin or after senolytics, I think all of which are due to reducing inflammation. I wonder if the dose needed for similar effects would be much higher.

---

<div class="post-metadata">

**Author:** ![LeeJohn](https://www.rapamycin.news/user_avatar/www.rapamycin.news/leejohn/32/672_2.png) [@LeeJohn](https://www.rapamycin.news/u/LeeJohn)\
**Post date:** [February 2, 2022, 8:13pm UTC](https://www.rapamycin.news/t/rapamycin-acarbose-and-17-estradiol-share-common-mechanisms-regulating-the-mapk-pathways-involved-in-intracellular-signaling-and-inflammation/668/5 "2022-02-02T20:13:17Z")

</div>

It’s surprising that Rapamycin, Acarbose and 17α-estradiol share common age-dependent pathway via MAPK pathways and MEK3/p38/MK2 pathway

> It has seemed plausible that lower inflammatory tone could contribute to the exceptionally healthy lifespan of these mutant mice. Our work here shows that diminished production of inflammatory mediators is also characteristic of mice whose longevity is caused by treatment with Rapa, ACA, or 17aE2

It looks like that all 3 compounds extend lifespan by lowering inflammation state, suggesting that inflammation really plays a strong key in aging progress.

I am curious if there are other compounds that can extend lifespan not by lowering inflammation state, then that can the next breakthrough

---

<div class="post-metadata">

**Author:** ![shc](https://www.rapamycin.news/user_avatar/www.rapamycin.news/shc/32/750_2.png) [@shc](https://www.rapamycin.news/u/shc)\
**Post date:** [February 2, 2022, 8:16pm UTC](https://www.rapamycin.news/t/rapamycin-acarbose-and-17-estradiol-share-common-mechanisms-regulating-the-mapk-pathways-involved-in-intracellular-signaling-and-inflammation/668/6 "2022-02-02T20:16:03Z")

</div>

It’s pretty cool that they have overlapping mechanisms, and they lower inflammation which is a hallmark of aging.

However I imagine that there is much to be said for the other not completely overlapping mechanisms too (e.g. mTOR, whatever 17-alphaestradiol does to men, etc.)

---

<div class="post-metadata">

**Author:** ![RapAdmin](https://www.rapamycin.news/user_avatar/www.rapamycin.news/rapadmin/32/377_2.png) [@RapAdmin](https://www.rapamycin.news/u/RapAdmin)\
**Post date:** [February 2, 2022, 8:29pm UTC](https://www.rapamycin.news/t/rapamycin-acarbose-and-17-estradiol-share-common-mechanisms-regulating-the-mapk-pathways-involved-in-intracellular-signaling-and-inflammation/668/7 "2022-02-02T20:29:07Z")

</div>

Yes - its very interesting… but I wonder how big a role the inflammation truly is as an influence in aging… how do we explain the differential effects of 17 alpha estradiol in men vs. women? I’m assuming that inflammation in men is no different than inflammation in women…

---

<div class="post-metadata">

**Author:** ![shc](https://www.rapamycin.news/user_avatar/www.rapamycin.news/shc/32/750_2.png) [@shc](https://www.rapamycin.news/u/shc)\
**Post date:** [February 2, 2022, 8:42pm UTC](https://www.rapamycin.news/t/rapamycin-acarbose-and-17-estradiol-share-common-mechanisms-regulating-the-mapk-pathways-involved-in-intracellular-signaling-and-inflammation/668/8 "2022-02-02T20:42:17Z")

</div>

We do need to remember that improvements in hallmarks of aging tend to be correlated with each other. Based on this, inflammation reduction should be expected of all longevity interventions. But that apart, it’s pretty interesting that MAPK is implicated in each of these 3 molecules.

---

<div class="post-metadata">

**Author:** ![AlexKChen](https://www.rapamycin.news/user_avatar/www.rapamycin.news/alexkchen/32/385_2.png) [@AlexKChen](https://www.rapamycin.news/u/AlexKChen)\
**Post date:** [February 2, 2022, 8:55pm UTC](https://www.rapamycin.news/t/rapamycin-acarbose-and-17-estradiol-share-common-mechanisms-regulating-the-mapk-pathways-involved-in-intracellular-signaling-and-inflammation/668/9 "2022-02-02T20:55:29Z")

</div>

So does it still work if you’re keto or eat fruit?

---

<div class="post-metadata">

**Author:** ![Maveric78](https://www.rapamycin.news/user_avatar/www.rapamycin.news/maveric78/32/1638_2.png) [@Maveric78](https://www.rapamycin.news/u/Maveric78)\
**Post date:** [February 3, 2022, 9:15am UTC](https://www.rapamycin.news/t/rapamycin-acarbose-and-17-estradiol-share-common-mechanisms-regulating-the-mapk-pathways-involved-in-intracellular-signaling-and-inflammation/668/10 "2022-02-03T09:15:54Z")

</div>

@shc could you expand on what you mean by a ‘body high’? Is this reflected in any acute bio markers, eg HRV or sleep

---

<div class="post-metadata">

**Author:** ![shc](https://www.rapamycin.news/user_avatar/www.rapamycin.news/shc/32/750_2.png) [@shc](https://www.rapamycin.news/u/shc)\
**Post date:** [February 3, 2022, 10:20am UTC](https://www.rapamycin.news/t/rapamycin-acarbose-and-17-estradiol-share-common-mechanisms-regulating-the-mapk-pathways-involved-in-intracellular-signaling-and-inflammation/668/11 "2022-02-03T10:20:00Z")

</div>

Ah sorry I was reporting a subjective experience. But CRP levels I believe would be a good biomarker to capture this.

---

<div class="post-metadata">

**Author:** ![Maveric78](https://www.rapamycin.news/user_avatar/www.rapamycin.news/maveric78/32/1638_2.png) [@Maveric78](https://www.rapamycin.news/u/Maveric78)\
**Post date:** [February 3, 2022, 10:53am UTC](https://www.rapamycin.news/t/rapamycin-acarbose-and-17-estradiol-share-common-mechanisms-regulating-the-mapk-pathways-involved-in-intracellular-signaling-and-inflammation/668/12 "2022-02-03T10:53:56Z")

</div>

I’ve had the same experience but had put it down to the placebo effect. It’s like having a double espresso
